Form 4: Paychex Director Kevin A. Price Acquires Shares and Stock Options
SEC Form 4
Director Kevin A. Price reports acquisition of Paychex shares and stock options.
Summary
- On July 15, 2024, Kevin A. Price, a director of Paychex Inc., acquired 761 shares of common stock.
- These shares were awarded as restricted stock units under the Amended and Restated 2002 Stock Incentive Plan.
- Price also acquired 3,351 stock options with an exercise price of $121.63, exercisable from July 15, 2025, and expiring on July 14, 2034.
- Following these transactions, Price directly owns 3,062 shares of Paychex common stock.
- Price also holds derivative securities including 5,075 stock options with an exercise price of $112.67, exercisable from July 15, 2022, and expiring on July 14, 2031.
- Price also holds derivative securities including 3,027 stock options with an exercise price of $115, exercisable from July 15, 2023, and expiring on July 14, 2032.
- Price also holds derivative securities including 3,382 stock options with an exercise price of $120.86, exercisable from July 15, 2024, and expiring on July 14, 2033.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The form simply reports transactions. The director's acquisition could be seen as a positive signal, but it's not definitive.
Positives
- Director's acquisition of shares and options may signal confidence in the company's future performance.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's prospects; however, they do not always indicate a definitive trend.
Stakeholder Impact
- The reported transactions may influence investor perception of Paychex.
Key Dates
| Date | Description |
|---|---|
| 07/15/2022 | Date from which 5,075 stock options with an exercise price of $112.67 are exercisable. |
| 07/15/2023 | Date from which 3,027 stock options with an exercise price of $115 are exercisable. |
| 07/15/2024 | Date of transaction: acquisition of 761 shares and 3,351 stock options with an exercise price of $121.63; Date from which 3,382 stock options with an exercise price of $120.86 are exercisable. |
| 07/15/2025 | Date from which 3,351 stock options with an exercise price of $121.63 are exercisable. |
| 07/14/2031 | Expiration date for 5,075 stock options with an exercise price of $112.67. |
| 07/14/2032 | Expiration date for 3,027 stock options with an exercise price of $115. |
| 07/14/2033 | Expiration date for 3,382 stock options with an exercise price of $120.86. |
| 07/14/2034 | Expiration date for 3,351 stock options with an exercise price of $121.63. |
| 07/17/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.